CHEST Physician
-
Adult bronchiectasis guidelines updated to reflect emerging evidence on disease identification and management
New bronchiectasis recommendations from the European Respiratory Society reflect a shift toward individualized, risk-based care, recognizing diverse inflammatory and microbiologic profiles. The guidelines emphasize early identification of high-risk patients, multidimensional assessment, and universal airway clearance training.
-
Black lung disease mortality on the rise, recent analysis shows
CDC experts David N. Weissman, MD, FCCP, and Jacek Mazurek, MD, PhD, said that identifying dust exposure is key to improving outcomes for patients with coal workers’ pneumoconiosis.
-
Artificial intelligence promises to reshape the business of health care
Artificial intelligence tools have shown they can improve efficiency; however, concerns arise when the line between administrative tasks and patient care blurs.
-
Text-message program may aid smoking cessation in patients with TB
A recent trial highlights the impact of a mobile health-based initiative to aid in smoking cessation within TB treatment programs, said author Maham Zahid, PhD.
-
Sotatercept in pulmonary arterial hypertension
Understanding when to consider sotatercept and how to use it has become a critical part of PAH care.
-
Lung cancer survivorship: Life beyond diagnosis, treatment, and rechecks
It is no longer enough to “survive” lung cancer; our responsibility as pulmonologists is to help survivors persevere beyond it.
-
The physiology of near drowning
Drowning is an underrecognized global health care burden across the world. Review what the experts discussed on the topic in a recorded session from CHEST 2025.
-
Unifying care across academic and community systems
The integration of academic and community physician groups within academic health systems offers a powerful opportunity to elevate women as leaders of change.
-
AASM issues first guideline for inpatient management of OSA
Sleep specialist Dennis H. Auckley, MD, FCCP, said he hopes the recommendations move the field into the inpatient setting and help to identify those with undiagnosed sleep apnea.
-
Data support use of nirsevimab prophylaxis to reduce RSV hospitalization risk for infants
Retrospective data show significantly fewer infants were hospitalized for RSV after nirsevimab became available. Among the RSV hospitalizations that occurred during that time period, 75% were in infants who had not received nirsevimab.
